news

Two global biopharmaceutical companies join effort to address the growing non-communicable disease burden in low- and middle-income countries

GENEVA, SWITZERLAND – Today, Ipsen and Servier, two global biopharmaceutical companies, joined Access Accelerated, an initiative aimed at advancing access to non-communicable disease (NCD) prevention, treatment and care in low- and middle income countries (LMICs). Together with partners from across the global biopharmaceutical sector, multilateral organizations and non-governmental organizations, Access Accelerated works toward a future where no one dies prematurely from treatable, preventable diseases.Read More


Access Accelerated returned to Kenya from 28 February to 1 March for the non-communicable diseases (NCDs) stakeholder meeting, “Redefining UHC – the Opportunity for NCDs,” co-hosted with the Ministry of Health and NCD Alliance Kenya in Naivasha. With representation from the Kenyan government across ministries and attendees that spanned civil society, representatives from 12 Access Accelerated member companies, people living with NCDs (PLWNCDs) and government officials from six African nations, the meeting provided a forum to reflect on progress made and recommit to increasing access to NCD treatment and care in the context of the country’s push toward Universal Health Coverage (UHC).
Read More

press releases

Celgene Launches Celgene Cancer Care Links TM to Support Cancer Healthcare Capacity Building in Resource-Constrained Countries

Grant Program Will Help Fund Cancer Care Capability, Delivery and Access Programs 

SUMMIT, NJ, December 5, 2017 – Celgene Corporation (NASDAQ:CELG) today announced the launch of Celgene Cancer Care Links, a new grant program designed to support cancer healthcare capacity building in resource-constrained countries around the world. As part of this program, Celgene will collaborate with medical centers focused on enhancing patient care and building sustainable cancer care systems in resourceconstrained countries. Funding will be provided to approved programs in 2018.
Read More

22 Biopharma Companies Partner and Launch First-of-its-kind Global Initiative to Address Rise of Non-Communicable Diseases

At the 2017 World Economic Forum in Davos, Switzerland, twenty-two leading biopharmaceutical companies launched Access Accelerated, a global initiative to advance access to non-communicable disease (NCD) prevention and care in low and middle income countries.

newsletters

Access Accelerated returned to Kenya on 28 February and 1 March for the non-communicable diseases (NCD) stakeholder meeting, “Redefining UHC – the Opportunity for NCDs,” cohosted with the Ministry of Health and NCD Alliance Kenya in Naivasha, Kenya.

With representation from the Kenyan government across ministries and attendees that spanned civil society, representatives from 12 Access Accelerated member companies, people living with NCDs (PLWNCDs) and government officials from six African nations, the meeting provided a forum to reflect on progress made and recommit to increasing access to NCD treatment and care in the context of the country’s push toward Universal Health Coverage (UHC).Read More

Videos

Possibilities

We believe a life not defined by disease is a life of possibility.